Macheal Laboratories Limited - Due diligence report

A 360° intelligence report on Macheal Laboratories Limited: trust score, financial health, credit view, compliance, directors, growth and di…

2003-06-27 Na, Gujarat Active Unlisted Active Compliant
Share
ML Macheal Laboratories Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Macheal Laboratories Limited — 360° Intelligence Report

Generated from MCA filings & public records
85/100
Trust Score
Low Risk

Macheal Laboratories Limited is assessed as Low Risk with a Trust Score of 85/100. Macheal Laboratories Limited is an active public limited indian non-government company incorporated in 2003, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 20 Jul 2026 from the latest processed filings. Macheal Laboratories Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
85/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
83/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
45/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 83/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 1 court forum(s).
  • 1 auditor resignation(s) filed - latest: UDAY I SHAH & CO. on 2018-06-21.
  • 2 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
AMAN VIPUL MOHAN 01234567 Director 01/04/2018 6 yrs Approved
PAYAL MOHAN 01234567 Director 01/04/2018 6 yrs Approved
VIPUL MOHAN 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Amegh Pharma Private Limited
Subsidiaries
-
Group entities
-
Capital events
0 allotment(s) · 8 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Amegh Pharma Private Limited Holding Company 74.00%

Key managerial personnel: PAYAL MOHAN (Whole-time director) · VIPUL MOHAN (Whole-time director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 45 · Distress 75
Growth signals & trust indicators
Net margin improved to 2.1x.
Operating for 23+ years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
1 auditor resignation(s) on record - review the stated reasons.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence81/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment88/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view67/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
31 Mar 2019
Share transfer (FY 2019)
1168.00000000 shares to VIPUL VIRENDRAKUMAR MOHAN
Share transfer (FY 2019)
1168.00000000 shares to PAYAL VIPUL MOHAN
Share transfer (FY 2019)
1168.00000000 shares to AMAN VIPUL MOHAN
Share transfer (FY 2019)
8995.00000000 shares to AMEGH PHARMA PVT. LTD.
Share transfer (FY 2019)
12498.00000000 shares to AMEGH PHARMA PVT. LTD.
Share transfer (FY 2019)
1.00000000 shares to VIRENDRA KUMAR MOHAN
Share transfer (FY 2019)
1.00000000 shares to SANJIV CHHIBBER
Share transfer (FY 2019)
1.00000000 shares to VINITA CHHIBBER
02 Jan 2019
Director ceased
KRIPA SANJAY SHAH
02 Apr 2018
Director appointed
AMAN VIPUL MOHAN (Additional Director)
30 Apr 2016
Director ceased
RUTWA VIJAYKUMAR SHAH
Director ceased
PAYAL MOHAN
Director ceased
VIPUL MOHAN
10

Key Observations

Auto-generated from the data above
Revenue declined 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Riya Trade International Private Limited U51501GJ2020PTC113384 Ahmedabad, Gujarat, India
Sucopeia Referencestandards (Opc) Private Limited U74900KA2015OPC084592 Bangalore, Karnataka, India
Bio Digital Private Limited U74999DL2001PTC110794 New Delhi, Delhi, India
Meghna Overseas Private Limited U51909WB2002PTC095315 Domjur, West Bengal, India
Nuvo Home Fashions Private Limited U18101DL2005PTC143993 New Delhi, Delhi, India
Quadrant Pole Private Limited U74110TN2017PTC117143 Madurai North, Tamil Nadu, India
Riyan Steel Private Limited U51101MH2012PTC237150 Navi Mumbai, Maharashtra, India
A. W. Constructions Private Limited U45200MP2009PTC022110 Bhopal, Madhya Pradesh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Macheal Laboratories Limited before audits and certifications: compliance score 83/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Macheal Laboratories Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 45/100, margin trends, ownership structure and peer set for Macheal Laboratories Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 85/100, distress signals and MSME payment-delay disclosures - know whether Macheal Laboratories Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Macheal Laboratories Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Macheal Laboratories Limited an active company?

Macheal Laboratories Limited has MCA status “Active” with a compliance score of 83/100 (Low Risk).

Is Macheal Laboratories Limited financially healthy?

Macheal Laboratories Limited has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.

Should I do business with Macheal Laboratories Limited?

Its overall Trust Score is 85/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Macheal Laboratories Limited?

The ultimate holding entity is Amegh Pharma Private Limited. 3 active director(s) are on record.

Does Macheal Laboratories Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Macheal Laboratories Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 83/100 (Low Risk).

Is it risky to lend to Macheal Laboratories Limited?

Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.